|
EP2968155B1 |
03 Mar, 2021
|
Tofacitinib Oral Sustained Release Dosage Forms
|
Mar, 2034
|
6
| |
|
EP3302565B1 |
06 Nov, 2019
|
Solid Dosage Forms Of Palbociclib
|
May, 2036
|
6
| |
|
EP3191461B1 |
03 Nov, 2021
|
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole
|
Aug, 2035
|
5
| |
|
EP3431475B1 |
07 Apr, 2021
|
Solid Forms Of A Selective Cdk4/6 Inhibitor
|
Feb, 2034
|
4
| |
|
EP3096785B1 |
09 Sep, 2020
|
Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens And Uses Thereof
|
Jan, 2035
|
3
| |
|
EP2958916B1 |
12 Sep, 2018
|
Solid Forms Of A Selective Cdk4/6 Inhibitor
|
Feb, 2034
|
3
| |
|
EP2357250B1 |
06 Oct, 2021
|
Production Of Polypeptides
|
Aug, 2025
|
2
| |
|
EP1789571B1 |
26 Apr, 2017
|
Production Of Polypeptides
|
Aug, 2025
|
2
| |
|
EP2134702B2 |
30 Aug, 2023
|
Crystalline Forms Of 6-[2-(Methylcarbamoyl)Phenylsulfanyl]-3-E-[2-(Pyridin-2-Yl)Ethenyl]Indazole Suitable For The Treatment Of Abnormal Cell Growth In Mammals
|
Mar, 2028
|
1
| |
|
EP3269717B9 |
09 Aug, 2023
|
Polymorphic And Pseudopolymorphic Forms Of Pharmaceutical Compound Nxl104
|
Oct, 2030
|
1
| |
|
EP3555064B9 |
01 Mar, 2023
|
Glp-1 Receptor Agonists And Uses Thereof
|
Dec, 2037
|
1
| |
|
EP3459578B1 |
03 Mar, 2021
|
Dispensing Device
|
Jun, 2024
|
1
| |
|
EP3150610B1 |
31 Jul, 2019
|
Salts And Polymorphs Of 8-Fluoro-2-{4-[(Methylamino}Methyl]Phenyl}-1,3,4,5-Tetrahydro-6H-Azepino[5,4,3-Cd]Indol-6-One
|
Feb, 2031
|
1
| |
|
EP2752216B1 |
07 Nov, 2018
|
Dispensing Device
|
Jun, 2024
|
1
| |
